Cited by 620Systemic Lupus Erythematosus ResearchReproductive System and PregnancyBlood Coagulation and Thrombosis Mechanisms

The DOI matches its Crossref record; 89 of the 89 references it cites were found in a registry or an index.

Pathogenesis of antiphospholipid syndrome: understanding the antibodies

Meroni, Pier Luigi, Borghi, M. Orietta, Raschi, Elena, Tedesco, Francesco·2011·Nature Reviews Rheumatology

DOI 10.1038/nrrheum.2011.52

Open this paper in CoChat — free account

Abstract

Antiphospholipid antibodies (aPL) are both diagnostic markers for, and pathogenic drivers of, antiphospholipid syndrome (APS). Although the presence of aPL is a necessary pre-condition, APS-associated clotting is seemingly triggered by an additional 'second hit', frequently related to innate inflammatory immune responses. β(2) glycoprotein I (β(2)GPI)-dependent aPL, the most important subset of these antibodies, mediate several--not necessarily alternative--thrombogenic mechanisms, mainly on the basis of their reactivity with β(2)GPI expressed on the membrane of cells that participate in the coagulation cascade. Recurrent pregnancy complications associated with aPL cannot be explained solely by thrombosis, and alternative pathogenic mechanisms have been reported. Although one in vivo model of fetal loss suggests a mechanism of aPL-mediated acute placental inflammation, other models and the histopathological examination of APS placentae do not support a widespread inflammatory signature. β(2)GPI-dependent aPL are thought to recognize their antigen on placental tissues, inhibit the growth and differentiation of trophoblasts, and eventually cause defective placentation. Why antibodies with similar antigen specificity produce different clinical manifestations is not clear. Characterization of the molecular basis of the pathogenic mechanisms involved, including the putative second hits and the role of complement activation, might offer an answer to this question.

Integrity signals

Registry

Crossref · 10.1038/nrrheum.2011.52

Cites

89 of 89 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS)
MIYAKIS, S., LOCKSHIN, M. D., ATSUMI, T., BRANCH, D. W., BREY, R. L., CERVERA, R., DERKSEN, R. H. W. M., DE GROOT, P. G., KOIKE, T., MERONI, P. L., et al. (2006) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2006.01753.x · Cited by 7,203
Self-citation
Antiphospholipid syndrome
Ruiz‐Irastorza, G., Crowther, M. A., Branch, W. D., & Khamashta, M. A. (2010) · The Lancet · doi:10.1016/s0140-6736(10)60709-x · Cited by 875
Pivotal role for neuronal Toll-like receptors in ischemic brain injury and functional deficits
Tang, S.-C., Arumugam, T. V., Xu, X., Cheng, A., Mughal, M. R., Jo, D. G., Lathia, J. D., Siler, D. A., Chigurupati, S., Ouyang, X., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0702553104 · Cited by 779
Complement C5a receptors and neutrophils mediate fetal injury in the antiphospholipid syndrome
Girardi, G., Berman, J., Redecha, P. B., Spruce, L. A., Thurman, J. M., Kraus, D., Hollmann, T. J., Casali, P., Caroll, M. C., Wetsel, R. A., et al. (2003) · Journal of Clinical Investigation · doi:10.1172/jci18817 · Cited by 691
Heparin prevents antiphospholipid antibody–induced fetal loss by inhibiting complement activation
Girardi, G., Redecha, P. B., & Salmon, J. E. (2004) · Nature Medicine · doi:10.1038/nm1121 · Cited by 680
Complement C3 Activation Is Required for Antiphospholipid Antibody-induced Fetal Loss
Holers, V. M., Girardi, G., Mo, L., Guthridge, J. M., Molina, H. D., Pierangeli, S. S., Espinola, R. G., Xiaowei, L. E., Mao, D., Vialpando, C. G., et al. (2002) · The Journal of Experimental Medicine · doi:10.1084/jem.200116116 · Cited by 625
Complement C5a receptors and neutrophils mediate fetal injury in the antiphospholipid syndrome
Girardi, G., Berman, J., Redecha, P. B., Spruce, L. A., Thurman, J. M., Kraus, D., Hollmann, T. J., Casali, P., Caroll, M. C., Wetsel, R. A., et al. (2003) · Journal of Clinical Investigation · doi:10.1172/jci200318817 · Cited by 593
Repeated fetal losses associated with antiphospholipid antibodies: A collaborative randomized trial comparing prednisone with low-dose heparin treatment
Cowchock, F. S., Reece, E. A., Balaban, D. J., Branch, D. W., & Plouffe, L. (1992) · American Journal of Obstetrics and Gynecology · doi:10.1016/0002-9378(92)91596-3 · Cited by 585
Complement activation induces dysregulation of angiogenic factors and causes fetal rejection and growth restriction
Girardi, G., Yarilin, D. A., Thurman, J. M., Holers, V. M., & Salmon, J. E. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20061022 · Cited by 509
Anti–β2-glycoprotein I, antiprothrombin antibodies, and the risk of thrombosis in the antiphospholipid syndrome
Galli, M., Luciani, D., Bertolini, G., & Barbui, T. (2003) · Blood · doi:10.1182/blood-2002-11-3334 · Cited by 413

Show all 89 references

Research works printed but not linked: 5

Gerosa, M. et al. Complement involvement in antiphospholipid-mediated placental damage: prospective study in APS pregnant women [abstract THU0120] Ann. Rheum. Dis. 68 (Suppl. 3), 210 (2009).
Borghi, M. O. et al. Antiphospholipid antibodies reactivity with human decidual cells: an additional mechanism of pregnancy complications in APS and a potential target for innovative therapeutic intervention [abstract OP-0119]. Ann. Rheum. Dis. 68 (Suppl. 3), 109 (2009).
Raschi, E., Broggini, V., Borghi, M. O., Grossi, C. & Meroni, P. L. TLR-4 and Annexin A2 involvement in endothelial cell activation by anti-phospholipid antibodies: specific silencing by small interfering RNAs [abstract 1356]. Arthritis Rheum. 62 (Suppl.), S563 (2010).
Tedesco, F. Biodistribution of β2GPI in naive and immunized mice and in vivo pro-thrombotic effect of an anti-β2GPI minibody isolated from human phage display library [abstract A006]. Lupus 19, 497–498 (2010).
Ziglioli, T. et al. Low complement levels during pregnancy are associated with obstetric complications in patients with primary antiphospholipid syndrome [abstract THU0129]. Ann. Rheum. Dis. 68 (Suppl. 3), 213–214 (2009).

Sorted by citations

Items 201–300 of 620

Ruling out lupus anticoagulants with mixing test-specific cutoff assessment and the index of circulating anticoagulant
Kumano, O., & Moore, G. W. (2019) · Research and Practice in Thrombosis and Haemostasis · doi:10.1002/rth2.12245 · Cited by 24
Pathogenesis of the antiphospholipid syndrome revisited: time to challenge the dogma
Lackner, K. J., & Müller‐Calleja, N. (2016) · Journal of Thrombosis and Haemostasis · doi:10.1111/jth.13320 · Cited by 24
Vitamin D Reverses aPL ‐induced Inflammation and LMWH‐induced s F lt‐1 Release by Human Trophoblast
Gysler, S. M., Mulla, M. J., Stuhlman, M., Sfakianaki, A. K., Paidas, M. J., Stanwood, N. L., Gariepy, A. M., Brosens, J. J., Chamley, L., & Abrahams, V. M. (2014) · American Journal of Reproductive Immunology · doi:10.1111/aji.12301 · Cited by 24
LDLR and PCSK9 Are Associated with the Presence of Antiphospholipid Antibodies and the Development of Thrombosis in aPLA Carriers
Ochoa, E., Iriondo, M., Manzano, C., Fullaondo, A., Villar, I., Ruiz‐Irastorza, G., Zubiaga, A. M., & Estonba, A. (2016) · PLoS ONE · doi:10.1371/journal.pone.0146990 · Cited by 24
Effect of alpha‐lipoic acid and myoinositol on endometrial inflammasome from recurrent pregnancy loss women
Nicuolo, F. D., D’Ippolito, S., Castellani, R., Rossi, E. D., Masciullo, V., Specchia, M., Mariani, M., Pontecorvi, A., Scambia, G., & Simone, N. D. (2019) · American Journal of Reproductive Immunology · doi:10.1111/aji.13153 · Cited by 24
Beta 2 glycoprotein I and neutrophil extracellular traps: Potential bridge between innate and adaptive immunity in anti-phospholipid syndrome
Grossi, C., Capitani, N., Benagiano, M., Baldari, C. T., Bella, C. D., Macor, P., Tedesco, F., Borghi, M. O., Maugeri, N., D’Elios, M. M., et al. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2022.1076167 · Cited by 24
Self-citation
Improving Outcomes in Patients with Lupus and End‐Stage Renal Disease
Inda-Filho, A. J., Neugarten, J., Putterman, C., & Broder, A. R. (2013) · Seminars in Dialysis · doi:10.1111/sdi.12122 · Cited by 24
β 2 -Glycoprotein I/IgA Immune Complexes
Serrano, M., Martínez-Flores, J. A., Pérez, M. D., García, F., Cabrera, O., Pleguezuelo, D. E., Paz‐Artal, E., Morales, J. M., González, E., & Serrano, A. (2017) · Circulation · doi:10.1161/circulationaha.116.025992 · Cited by 24
Serological evolution in women with positive antiphospholipid antibodies
Riancho‐Zarrabeitia, L., Daroca, G., Muñoz, P., López‐Hoyos, M., Haya, A., & Martínez-Taboada, V. M. (2017) · Seminars in Arthritis and Rheumatism · doi:10.1016/j.semarthrit.2017.05.001 · Cited by 24
Primary Thrombosis Prophylaxis in Persistently Antiphospholipid Antibody-Positive Individuals: Where Do We Stand in 2018?
Zuo, Y., Barbhaiya, M., & Erkan, D. (2018) · Current Rheumatology Reports · doi:10.1007/s11926-018-0775-8 · Cited by 25
Synergistic Activation of Toll-Like and NOD Receptors by Complementary Antigens as Facilitators of Autoimmune Disease: Review, Model and Novel Predictions
Root-Bernstein, R. S. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21134645 · Cited by 24
The pathogenesis of obstetric APS: a 2023 update
Mineo, C., Shaul, P. W., & Bermas, B. L. (2023) · Clinical Immunology · doi:10.1016/j.clim.2023.109745 · Cited by 24
Pregnancy in antiphospholipid syndrome: what should a rheumatologist know?
Andréoli, L., Regola, F., Caproli, A., Crisafulli, F., Fredi, M., Lazzaroni, M. G., Nalli, C., Piantoni, S., Zatti, S., Franceschini, F., et al. (2023) · Rheumatology · doi:10.1093/rheumatology/kead537 · Cited by 24
B cells in primary antiphospholipid syndrome: Review and remaining challenges
Dieudonné, Y., Guffroy, A., Poindron, V., Soulas-Sprauel, P., Martin, T., Korganow, A., & Gies, V. (2021) · Autoimmunity Reviews · doi:10.1016/j.autrev.2021.102798 · Cited by 23
Protein Phosphatase 2A Activation Via ApoER2 in Trophoblasts Drives Preeclampsia in a Mouse Model of the Antiphospholipid Syndrome
Chu, H., Sacharidou, A., Nguyen, A. L., Li, C., Chambliss, K. L., Salmon, J. E., Shen, Y.-M., Lo, J. Y., Leone, G. W., Herz, J., et al. (2021) · Circulation Research · doi:10.1161/circresaha.120.318941 · Cited by 24
Circulating immune-complexes of IgG/IgM bound to B2-glycoprotein-I associated with complement consumption and thrombocytopenia in antiphospholipid syndrome
Naranjo, L., Stojanovich, L., Djoković, A., Andréoli, L., Tincani, A., Maślińska, M., Sciascia, S., Infantino, M. G., Garcinuño, S., Kostyra-Grabczak, K., et al. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.957201 · Cited by 23
Increased activity of interleukin-23/interleukin-17 cytokine axis in primary antiphospholipid syndrome
Popovic-Kuzmanovic, D., Novaković, I. V., Stojanovich, L., Aksentijevich, I. A., Zogovic, N. S., Tovilović-Kovačević, G., & Trajković, V. (2012) · Immunobiology · doi:10.1016/j.imbio.2012.03.002 · Cited by 23
Antiphospholipid Antibodies: Their Origin and Development
Lackner, K. J., & Müller‐Calleja, N. (2016) · Antibodies · doi:10.3390/antib5020015 · Cited by 23
Tandem autologous/allogeneic hematopoietic cell transplantation with bortezomib maintenance therapy for high-risk myeloma
Green, D. J., Maloney, D. G., Storer, B. E., Sandmaier, B. M., Holmberg, L. A., Becker, P. S., Fang, M., Martin, P. J., Georges, G. E., Bouvier, M. E., et al. (2017) · Blood Advances · doi:10.1182/bloodadvances.2017010686 · Cited by 23
Anti-phospholipid IgG antibodies detected by line immunoassay differentiate patients with anti-phospholipid syndrome and other autoimmune diseases
Nalli, C., Somma, V., Andréoli, L., Büttner, T., Schierack, P., Mähler, M., Roggenbuck, D., & Tincani, A. (2018) · Autoimmunity Highlights · doi:10.1007/s13317-018-0106-0 · Cited by 23
Presence of Extra-Criteria Antiphospholipid Antibodies Is an Independent Risk Factor for Ischemic Stroke
Naranjo, L., Ostos, F., Gil‐Etayo, F. J., Hernández‐Gallego, J., Cabrera-Marante, Ó., Pleguezuelo, D. E., Díaz‐Simón, R., Cerro, M., Lora, D., Martínez‐Salio, A., et al. (2021) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2021.665741 · Cited by 23
An in-office wire-bending robot for lingual orthodontics.
Gilbert, A. (2011) · PubMed · Cited by 23
RETRACTED ARTICLE: Antiphospholipid antibodies inhibit the migration and invasion of trophoblast cells by suppressing the JNK/C-Jun/MMP1 signaling pathway
Wang, Q., Feng, W., Tan, Y., Qiao, J., Liu, H., Liu, Q., Wang, H., Zhang, Q., Tao, J., Li, Z., et al. (2025) · Journal of Translational Medicine · doi:10.1186/s12967-025-06596-y · Cited by 22
Retracted
Prevention & treatment of obstetrical complications in APS: Is hydroxychloroquine the Holy Grail we are looking for?
Meroni, P. L. (2016) · Journal of Autoimmunity · doi:10.1016/j.jaut.2016.07.003 · Cited by 22
Self-citation
Antiphospholipid autoantibody detection is important in all patients with systemic autoimmune diseases
Marziale, A., Bettacchioli, É., Picart, G., Nafai, S., Galinat, H., Meroni, P. L., Frostegård, J., Alarcón-Riquelme, M. E., & Renaudineau, Y. (2020) · Journal of Autoimmunity · doi:10.1016/j.jaut.2020.102524 · Cited by 22
Self-citation
Differences in Antiphospholipid Antibody Profile between Patients with Obstetric and Thrombotic Antiphospholipid Syndrome
Anunciación-Llunell, A., Muñoz, C. M., Roggenbuck, D., Frasca, S., Pardos‐Gea, J., Esteve‐Valverde, E., Alijotas‐Reig, J., & Miró‐Mur, F. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232112819 · Cited by 22
Prevalence, clinical significance, and persistence of autoantibodies in COVID-19
Lee, S. J., Yoon, T., Ha, J. W., Kim, J. N., Lee, K. H., Lee, J. A., Kim, C. H., Lee, S., Kim, J. H., Ahn, J. Y., et al. (2023) · Virology Journal · doi:10.1186/s12985-023-02191-z · Cited by 22
Recent advances in the antiphospholipid antibody syndrome
Chaturvedi, S., & McCrae, K. R. (2014) · Current Opinion in Hematology · doi:10.1097/moh.0000000000000067 · Cited by 22
Molecular mapping of α-thrombin (αT)/β2-glycoprotein I (β2GpI) interaction reveals how β2GpI affects αT functions
Acquasaliente, L., Peterle, D., Tescari, S., Pozzi, N., Pengo, V., & Filippis, V. D. (2016) · Biochemical Journal · doi:10.1042/bcj20160603 · Cited by 22
Anti-β2-glycoprotein I antibody with DNA binding activity enters living monocytes via cell surface DNA and induces tissue factor expression
Virachith, S., Saito, M., Watanabe, Y., Inoue, K., Hoshi, O., & Kubota, T. (2018) · Clinical & Experimental Immunology · doi:10.1111/cei.13229 · Cited by 22
Antiphospholipid Syndrome and Renal Allograft Thrombosis
Morales, J. M., Serrano, M., Martínez-Flores, J. A., Pérez, M. D., & Serrano, A. (2018) · Transplantation · doi:10.1097/tp.0000000000002510 · Cited by 22
Antiphospholipid antibody syndrome
Yang, P. G., Kruh, J. N., & Foster, C. S. (2012) · Current Opinion in Ophthalmology · doi:10.1097/icu.0b013e328358b937 · Cited by 22
B-Cells and BAFF in Primary Antiphospholipid Syndrome, Targets for Therapy?
van den Hoogen, L. L., & Bisoendial, R. J. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm12010018 · Cited by 22
Single or triple positivity for antiphospholipid antibodies in “carriers” or symptomatic patients: Untangling the knot
Bertin, D., Camoin‐Jau, L., Veit, V., Resseguier, N., Lambert, M., Buffet Delmas, P., Heim, X., Mège, J., Morange, P., & Bardin, N. (2021) · Journal of Thrombosis and Haemostasis · doi:10.1111/jth.15518 · Cited by 21
Effects of anti‐beta 2‐glycoprotein 1 antibodies and its association with pregnancy‐related morbidity in antiphospholipid syndrome
Fierro, J. J., Velásquez, M., Cadavid, A. P., & de Leeuw, K. (2021) · American Journal of Reproductive Immunology · doi:10.1111/aji.13509 · Cited by 21
Antibodies to Phosphatidylserine/Prothrombin Complex in Antiphospholipid Syndrome
Peterson, L. K., Willis, R., Harris, E. N., Branch, W. D., & Tebo, A. E. (2016) · Advances in clinical chemistry · doi:10.1016/bs.acc.2015.10.003 · Cited by 21
Anti-phospholipid Antibodies and Smoking: An Overview
Binder, S. R., & Litwin, C. M. (2016) · Clinical Reviews in Allergy & Immunology · doi:10.1007/s12016-016-8565-4 · Cited by 21
Thrombin activatable fibrinolysis inhibitor (TAFI) — A possible link between coagulation and complement activation in the antiphospholipid syndrome (APS)
Grosso, G., Vikerfors, A., Woodhams, B. J., Adam, M., Bremme, K. A., Holmström, M., Ågren, A., Eelde, A., Bruzelius, M., Svenungsson, E., et al. (2017) · Thrombosis Research · doi:10.1016/j.thromres.2017.06.028 · Cited by 21
Prevalence of Antiphospholipid Antibodies Negativisation in Patients with Antiphospholipid Syndrome: A Long-Term Follow-Up Multicentre Study
Radin, M., Schreiber, K. I., Sciascia, S., Roccatello, D., Cecchi, I., Aguirre, M. A., & Cuadrado, M. J. (2019) · Thrombosis and Haemostasis · doi:10.1055/s-0039-1696687 · Cited by 21
Antiphospholipid syndrome: 30 years and our contribution
Koike, T. (2014) · International Journal of Rheumatic Diseases · doi:10.1111/1756-185x.12438 · Cited by 21
Evolution of Antiphospholipid Syndrome
Arachchillage, D. J., & Pericleous, C. (2023) · Seminars in Thrombosis and Hemostasis · doi:10.1055/s-0042-1760333 · Cited by 21
Detection of circulating immune complexes of human IgA and beta 2 glycoprotein I in patients with antiphospholipid syndrome symptomatology
Martínez-Flores, J. A., Serrano, M., Pérez, M. D., Lora, D., Paz‐Artal, E., Morales, J. M., & Serrano, A. (2015) · Journal of Immunological Methods · doi:10.1016/j.jim.2015.04.002 · Cited by 20
Anti-Phospholipid Antibodies and COVID-19 Thrombosis: A Co-Star, Not a Supporting Actor
Gil‐Etayo, F. J., Garcinuño, S., Lalueza, A., Díaz‐Simón, R., García‐Reyne, A., Pleguezuelo, D. E., Cabrera-Marante, Ó., Rodriguez-Frias, E. A., Pérez‐Rivilla, A., Serrano, M., et al. (2021) · Biomedicines · doi:10.3390/biomedicines9080899 · Cited by 20
Anticardiolipin and/or anti-β2-glycoprotein-I antibodies are associated with adverse IVF outcomes
Wu, L., Fang, X., Lu, F., Zhang, Y., Wang, Y., & Kwak-Kim, J. Y.-H. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.986893 · Cited by 19
Damage measured by Damage Index for Antiphospholipid Syndrome (DIAPS) in antiphospholipid antibody-positive patients included in the APS ACTION registry
Balbi, G. G. M., Ahmadzadeh, Y., Tektonidou, M. G., Pengo, V., Sciascia, S., Ugarte, A., Belmont, M. H., López-Pedrera, C., Fortin, P. R., Wahl, D. G., et al. (2023) · Rheumatology · doi:10.1093/rheumatology/kead292 · Cited by 19
Self-citation
Structural analyses of β2-glycoprotein I: is there a circular conformation?
Kumar, S., Wulf, J., Basore, K., & Pozzi, N. (2023) · Journal of Thrombosis and Haemostasis · doi:10.1016/j.jtha.2023.07.016 · Cited by 19
Antiphospholipid Antibodies Attenuate Endothelial Repair and Promote Neointima Formation in Mice
Ulrich, V., Konaniah, E. S., Lee, W., Khadka, S., Shen, Y.-M. P., Herz, J., Salmon, J. E., Hui, D. Y., Shaul, P. W., & Mineo, C. (2014) · Journal of the American Heart Association · doi:10.1161/jaha.114.001369 · Cited by 19
The association between IgG and IgM antibodies against cardiolipin, β2-glycoprotein I and Domain I of β2-glycoprotein I with disease profile in patients with multiple sclerosis
Filippidou, N., Krashias, G., Pericleous, C., Rahman, A., Ioannou, Y., Giles, I., Demetriou, C. A., Anatolitou, A., Christodoulou, C., Pantzaris, M., et al. (2016) · Molecular Immunology · doi:10.1016/j.molimm.2016.05.022 · Cited by 19
Inherited and acquired thrombophilia in Indian women experiencing unexplained recurrent pregnancy loss
Patil, R., Ghosh, K., Vora, S., & Shetty, S. (2015) · Blood Cells Molecules and Diseases · doi:10.1016/j.bcmd.2015.06.008 · Cited by 19
The digestive system involvement of antiphospholipid syndrome: pathophysiology, clinical characteristics, and treatment strategies
Zhang, J., Li, C., Han, X., Chen, Z., Adhikari, B. K., Wang, Y., Wang, Y., & Sun, J. (2021) · Annals of Medicine · doi:10.1080/07853890.2021.1962964 · Cited by 18
Brief Report: A Polymorphism in TLR2 Is Associated With Arterial Thrombosis in a Multiethnic Population of Patients With Systemic Lupus Erythematosus
Kaiser, R., Tang, L. F. P., Taylor, K. E., Sterba, K., Nititham, J., Brown, E. E., Edberg, J. C., McGwin, G., Alarcón, G. S., Ramsey‐Goldman, R., et al. (2014) · Arthritis & Rheumatology · doi:10.1002/art.38520 · Cited by 18
A novel 2-stage approach that detects complement activation in patients with antiphospholipid antibody syndrome
Rand, J. H., Wu, X.-X., Wolgast, L. R., Lei, V. J., & Conway, E. M. (2017) · Thrombosis Research · doi:10.1016/j.thromres.2017.06.014 · Cited by 18
Proximity-induced hybridization chain assembly with small-molecule linked DNA for single-step amplified detection of antibodies
Li, N., Liu, L., Xiang, M., Liu, J., Yu, R., & Jiang, J. (2019) · Chemical Communications · doi:10.1039/c9cc01654f · Cited by 18
What is known about pediatric antiphospholipid syndrome?
Meroni, P. L., Argolini, L. M., & Pontikaki, I. (2016) · Expert Review of Hematology · doi:10.1080/17474086.2016.1235969 · Cited by 18
Self-citation
Presence of Immune Complexes of IgG/IgM Bound to B2-glycoprotein I Is Associated With Non-criteria Clinical Manifestations in Patients With Antiphospholipid Syndrome
Pérez, M. D., Stojanovich, L., Naranjo, L., Stanisavljević, N., Bogdanovic, G., Serrano, M., & Serrano, A. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.02644 · Cited by 18
Antiphospholipid antibodies and COVID-19 thrombotic vasculopathy: one swallow does not make a summer
Meroni, P. L., & Borghi, M. O. (2021) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2021-220520 · Cited by 18
Self-citation
Catastrophic Antiphospholipid Syndrome: A Review of Current Evidence and Future Management Practices
Okunlola, A. O., Ajao, T. O., Sabi, M., Kolawole, O., Eweka, O. A., Karim, A., & Adebayo, T. E. (2024) · Cureus · doi:10.7759/cureus.69730 · Cited by 17
Anticoagulation in Management of Antiphospholipid Antibody Syndrome in Pregnancy
Lockshin, M. D. (2013) · Clinics in Laboratory Medicine · doi:10.1016/j.cll.2013.01.001 · Cited by 17
Effects of anti‐β2GPI antibodies on VWF release from human umbilical vein endothelial cells and ADAMTS13 activity
Ng, C. J., McCrae, K. R., Ashworth, K. J., Sosa, L. J., Betapudi, V., Manco‐Johnson, M. J., Liu, A., Dong, J., Chung, D. W., White‐Adams, T. C., et al. (2018) · Research and Practice in Thrombosis and Haemostasis · doi:10.1002/rth2.12090 · Cited by 17
Risk Factors for the Development of the Disease in Antiphospholipid Antibodies Carriers: A Long-term Follow-up Study
Pablo, R. Q., Muñoz, P., López‐Hoyos, M., Calvo-Río, V., Riancho‐Zarrabeitia, L., & Martínez-Taboada, V. M. (2021) · Clinical Reviews in Allergy & Immunology · doi:10.1007/s12016-021-08862-5 · Cited by 18
The trends in the incidence and thrombosis-related comorbidities of antiphospholipid syndrome: a 14-year nationwide population-based study
Yao, W.-C., Leong, K.-H., Chiu, L., Chou, P.-Y., Wu, L.-C., Chou, C.-Y., Kuo, C.-F., & Tsai, S. (2022) · Thrombosis Journal · doi:10.1186/s12959-022-00409-8 · Cited by 17
Pathogenesis of antiphospholipid syndrome: recent insights and emerging concepts
Lackner, K. J., & Müller‐Calleja, N. (2018) · Expert Review of Clinical Immunology · doi:10.1080/1744666x.2019.1546578 · Cited by 17
Impact of Systemic Lupus Erythematosus on Conception: Insights into Infertility, Fertility Preservation, Assisted Reproductive Technology, and Pregnancy Outcomes
Moyer, A., & Edens, C. (2024) · Seminars in Reproductive Medicine · doi:10.1055/s-0044-1793827 · Cited by 16
Gender differences in primary antiphospholipid syndrome with vascular manifestations in 433 patients from four European centres
Moschetti, L., Pozzolo, L. D., Guern, V. L., Morel, N., Yelnik, C., Lambert, M., HACHULLA, E., Benhamou, Y., Nalli, C., Fredi, M., et al. (2022) · Clinical and Experimental Rheumatology · doi:10.55563/clinexprheumatol/9royri · Cited by 16
Antiphospholipid Syndrome: State of the Art of Clinical Management
Depietri, L., Veropalumbo, M. R., Leone, M. C., & Ghirarduzzi, A. (2023) · Cardiovascular Drugs and Therapy · doi:10.1007/s10557-023-07496-3 · Cited by 16
Beyond the classics: The emerging value of anti-phosphatidylserine/prothrombin antibodies in antiphospholipid syndrome
Ding, Z., Pan, H., Yang, Z., Yang, C., & Shi, H. (2023) · Clinical Immunology · doi:10.1016/j.clim.2023.109804 · Cited by 16
Antiphospholipid antibodies in a large population-based cohort: genome-wide associations and effects on monocyte gene expression
Müller‐Calleja, N., Rossmann, H., Müller, C., Wild, P. S., Blankenberg, S., Pfeiffer, N., Binder, H., Beutel, M. E., Manukyan, D., Zeller, T., et al. (2016) · Thrombosis and Haemostasis · doi:10.1160/th15-12-0947 · Cited by 16
Renal involvement in primary antiphospholipid syndrome
Marcantoni, C., Emmanuele, C., & Scolari, F. (2016) · Journal of Nephrology · doi:10.1007/s40620-016-0317-2 · Cited by 16
Obstetric Anti-phospholipid Syndrome: State of the Art
Gerardi, M. C., Fernandes, M. A., Tincani, A., & Andréoli, L. (2018) · Current Rheumatology Reports · doi:10.1007/s11926-018-0772-y · Cited by 16
Direct oral anticoagulants in antiphospholipid syndrome with venous thromboembolism: Impact of the European Medicines Agency guidance
Fazili, M., Stevens, S. M., & Woller, S. C. (2019) · Research and Practice in Thrombosis and Haemostasis · doi:10.1002/rth2.12287 · Cited by 17
Additional risk factors associated with thrombosis and pregnancy morbidity in a unique cohort of antiphospholipid antibody-positive patients
Li, C., Zuo, Y., Zhang, S., Makris, U. E., Karp, D. R., & Li, Z. (2022) · Chinese Medical Journal · doi:10.1097/cm9.0000000000001964 · Cited by 16
Verification of the guidelines for lupus anticoagulant detection: usefulness of index for circulating anticoagulant in APTT mixing test
Kumano, O., Ieko, M., Naito, S., Yoshida, M., Takahashi, N., Suzuki, T., & Aoki, T. (2014) · Thrombosis Research · doi:10.1016/j.thromres.2014.05.030 · Cited by 15
Low-dose aspirin and heparin treatment improves pregnancy outcome in recurrent pregnancy loss women with anti-β2-glycoprotein I/HLA-DR autoantibodies: a prospective, multicenter, observational study
Tanimura, K., Saito, S., Tsuda, S., Ono, Y., Deguchi, M., Nagamatsu, T., Fujii, T., Nakatsuka, M., Kobashi, G., Arase, H., et al. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1445852 · Cited by 15
Autoantibody profiling in systemic lupus erythematosus
Yu, C., & Hsieh, S. (2013) · Current Biomarker Findings · doi:10.2147/cbf.s34496 · Cited by 15
Clinical value of anti-domain I-β2Glycoprotein 1 antibodies in antiphospholipid antibody carriers. A single centre, prospective observational follow-up study
Tonello, M., Mattia, E., Ross, T. D., Favarò, M., Calligaro, A., Hoxha, A., Bison, E., Pengo, V., & Ruffatti, A. (2018) · Clinica Chimica Acta · doi:10.1016/j.cca.2018.06.037 · Cited by 15
A Novel ELISA Assay for the Detection of Anti-Prothrombin Antibodies in Antiphospholipid Syndrome Patients at High Risk of Thrombosis
Chinnaraj, M., Pengo, V., & Pozzi, N. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.741589 · Cited by 15
Emerging Therapies in Antiphospholipid Syndrome
Hubben, A. K., & McCrae, K. R. (2022) · Transfusion Medicine Reviews · doi:10.1016/j.tmrv.2022.09.002 · Cited by 15
Elevated plasma level of soluble triggering receptor expressed on myeloid cells-1 is associated with inflammation activity and is a potential biomarker of thrombosis in primary antiphospholipid syndrome
Edel, Y., Kliminski, V., Pokroy‐Shapira, E., Oren, S., Lazar, A. D., Basson, Y. P.-P., Egbaria, M., & Molad, Y. (2019) · Arthritis Research & Therapy · doi:10.1186/s13075-018-1779-5 · Cited by 16
Intracardiac thrombus in a patient with catastrophic antiphospholipid syndrome: an autopsy case report and review of the literature
Waisayarat, J., Plumworasawat, S., Vilaiyuk, S., & Sirachainan, N. (2019) · Vascular Health and Risk Management · doi:10.2147/vhrm.s197638 · Cited by 15
Xenobiotics Targeting Cardiolipin Metabolism to Promote Thrombosis in Zebrafish
Liu, H., Cui, H., Huang, Y., Gao, S., Tao, S., Hu, J., & Wan, Y. (2021) · Environmental Science & Technology · doi:10.1021/acs.est.0c08068 · Cited by 15
New insights into the molecular basis of the antiphospholipid syndrome
Mineo, C., & Shaul, P. W. (2011) · Drug Discovery Today Disease Mechanisms · doi:10.1016/j.ddmec.2011.12.002 · Cited by 15
Immunoglobulin G is the only anti-beta-2-glycoprotein I isotype that associates with unprovoked thrombotic events among hospital patients
Brusch, A. M., Bundell, C. S., & Hollingsworth, P. (2014) · Pathology · doi:10.1097/pat.0000000000000070 · Cited by 14
Anti-domain 1 β2 glycoprotein antibodies increase expression of tissue factor on monocytes and activate NK Cells and CD8+ cells in vitro
Manukyan, G. P., Martirosyan, A., Slavík, L., Margaryan, S., Úlehlová, J., Mikulková, Z., Hluší, A., Papajík, T., & Kriegová, E. (2020) · Autoimmunity Highlights · doi:10.1186/s13317-020-00128-y · Cited by 14
Why thromboembolism occurs in some patients with thrombocytopenia and treatment strategies
Han, X., Li, C., Zhang, S., Hou, X., Chen, Z., Zhang, J. C., Zhang, Y., Sun, J., & Wang, Y. (2020) · Thrombosis Research · doi:10.1016/j.thromres.2020.10.005 · Cited by 14
Antigens and Antibodies of the Antiphospholipid Syndrome as New Allies in the Pathogenesis of COVID-19 Coagulopathy
Serrano, M., Espinosa, G., Serrano, A., & Cervera, R. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23094946 · Cited by 14
Plasminogen activator-coated nanobubbles targeting cellbound β2-glycoprotein I as a novel thrombus-specific thrombolytic strategy
Macor, P., Durigutto, P., Argenziano, M., Smith‐Jackson, K., Capolla, S., Leonardo, V. D., Marchbank, K. J., Tolva, V., Semeraro, F., Ammollo, C. T., et al. (2022) · Haematologica · doi:10.3324/haematol.2022.281505 · Cited by 14
Self-citation
International standards for IgG and IgM anti-β2glycoprotein antibody measurement
Willis, R., Grossi, C., Borghi, M. O., Martos-Sevilla, G., Zegers, I., Sheldon, J., & Meroni, P. L. (2014) · Lupus · doi:10.1177/0961203314544535 · Cited by 14
Self-citation
Kidney disease in primary anti-phospholipid antibody syndrome
Gracia-Tello, B., & Isenberg, D. A. (2016) · Rheumatology · doi:10.1093/rheumatology/kew307 · Cited by 14
Relapsing Evans syndrome and systemic lupus erythematosus with antiphospholipid syndrome treated with Bortezomib in combination with plasma exchange
Tkachenko, O. Y., Lapin, S. V., Maslyanskiy, А. L., Myachikova, V. Y., Mikhailova, L., & Gilburd, B. (2018) · Clinical Immunology · doi:10.1016/j.clim.2018.12.010 · Cited by 14
Cardiolipin interacts with beta‐2‐glycoprotein I and forms an open conformation–Mechanisms analyzed using hydrogen/deuterium exchange
Tang, K., Wu, T., Chen, H., Lin, C., & Hsu, Y. (2021) · Protein Science · doi:10.1002/pro.4054 · Cited by 14
Antiphospholipid antibodies as biomarkers in psychiatry: review of psychiatric manifestations in antiphospholipid syndrome
Rege, S., & Mackworth-Young, C. G. (2015) · Translational Developmental Psychiatry · doi:10.3402/tdp.v3.25452 · Cited by 14
New formulas for mixing test to discriminate between lupus anticoagulant and acquired hemophilia A
Kumano, O., Ieko, M., Naito, S., Yoshida, M., Takahashi, N., Suzuki, T., & Komiyama, Y. (2016) · Thrombosis Research · doi:10.1016/j.thromres.2016.05.004 · Cited by 13
Anti-phospholipid syndrome leading to digital ischaemia and rare organ complications in systemic sclerosis and related disorders
Chatterjee, S., & Pauling, J. D. (2020) · Clinical Rheumatology · doi:10.1007/s10067-020-05399-4 · Cited by 13
Aspirin and heparin in pregnancy
Grandone, E., Villani, M., & Tiscia, G. L. (2015) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.2015.1066335 · Cited by 15
Immunoreactivity and avidity of IgG anti-β2-glycoprotein I antibodies from patients with autoimmune diseases to different peptide clusters of β2-glycoprotein I
Artenjak, A., Locatelli, I., Brelih, H., Simonič, D. M., Ulcova-Gallova, Z., Swadźba, J., Musiał, J., Iwaniec, T., Stojanovich, L., Conti, F., et al. (2014) · Immunologic Research · doi:10.1007/s12026-014-8578-0 · Cited by 13
The dual role of innate immunity in antiphospholipid syndrome and systemic lupus erythematosus
Salem, D., Subang, R., Laplante, P., Levine, J. S., & Rauch, J. (2014) · Lupus · doi:10.1177/0961203314548248 · Cited by 13
Modulation of antiphospholipid antibodies‐induced trophoblast damage by different drugs used to prevent pregnancy morbidity associated with antiphospholipid syndrome
Álvarez, Á. M., Balcázar, N., Martín, S. S., Markert, U. R., & Cadavid, Á. P. (2017) · American Journal of Reproductive Immunology · doi:10.1111/aji.12634 · Cited by 13
β2-glycoprotein I and its antibodies involve in the pathogenesis of the antiphospholipid syndrome
Bai, A. (2017) · Immunology Letters · doi:10.1016/j.imlet.2017.03.013 · Cited by 13
Oxidation of β2-glycoprotein I associates with IgG antibodies to domain I in patients with antiphospholipid syndrome
Raimondo, M. G., Pericleous, C., Radziszewska, A., Borghi, M. O., Pierangeli, S. S., Meroni, P. L., Giles, I., Rahman, A., & Ioannou, Y. (2017) · PLoS ONE · doi:10.1371/journal.pone.0186513 · Cited by 13
Self-citation
Presence of Autoantibody Against Two Placental Proteins, Peroxiredoxin 3 and Peroxiredoxin 4, in Sera of Recurrent Pregnancy Loss Patients
Gharesi‐Fard, B., Jafarzadeh, L., Ghaderi‐shabankareh, F., Zolghadri, J., & Kamali‐Sarvestani, E. (2012) · American Journal of Reproductive Immunology · doi:10.1111/aji.12042 · Cited by 13

Authors: Meroni, P. L., Borghi, M. O., Raschi, E., & Tedesco, F.
Affiliations: University of Milan (IT)
IRCCS Istituto Auxologico Italiano (IT)
University of Trieste (IT)
Corresponding author: Meroni, Pier Luigi
ORCID: Meroni, Pier Luigi
Borghi, M. Orietta
Raschi, Elena
Tedesco, Francesco
Venue: Nature Reviews Rheumatology
Publisher: Springer Science and Business Media LLC
Published: 2011-05-10
Volume: 7
Issue: 6
Pages: 330-339
ISSN: 1759-4790 (ISSN-L)
1759-4804
DOI: 10.1038/nrrheum.2011.52
OpenAlex: W1999555834
Cited by: 620
References: 89
Citations by year: 2026: 38 · 2025: 34 · 2024: 35 · 2023: 34 · 2022: 39 · 2021: 47 · 2020: 34 · 2019: 41 · 2018: 43 · 2017: 43 · 2016: 54 · 2015: 33 · 2014: 63 · 2013: 37 · 2012: 36
FWCI: 6.72
Type: journal article
Language: en
Open access: closed
Licence: www.springer.com/tdm (tdm)
Locations: Nature Reviews Rheumatology (publishedVersion)
PubMed (publishedVersion)
Topics: Health Sciences › Medicine › Rheumatology › Systemic Lupus Erythematosus Research
Life Sciences › Immunology and Microbiology › Immunology › Reproductive System and Pregnancy
Health Sciences › Medicine › Hematology › Blood Coagulation and Thrombosis Mechanisms
Keywords: antiphospholipid syndrome, antiphospholipid antibodies, beta2-glycoprotein I, thrombosis, recurrent pregnancy loss, placental inflammation, trophoblast differentiation, complement activation, innate immune response, autoantibody pathogenesis
MeSH terms: Female, Humans, Pregnancy, Pregnancy Complications, Antiphospholipid Syndrome, Antibodies, Antiphospholipid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Pathogenesis of antiphospholipid syndrome: understanding the antibodies

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks